[go: up one dir, main page]

ES2063060T3 - Benzamida contra enfermedades cognoscitivas. - Google Patents

Benzamida contra enfermedades cognoscitivas.

Info

Publication number
ES2063060T3
ES2063060T3 ES89100901T ES89100901T ES2063060T3 ES 2063060 T3 ES2063060 T3 ES 2063060T3 ES 89100901 T ES89100901 T ES 89100901T ES 89100901 T ES89100901 T ES 89100901T ES 2063060 T3 ES2063060 T3 ES 2063060T3
Authority
ES
Spain
Prior art keywords
cognoscitive
diseases
benzamide
benzamide against
morpholinoethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89100901T
Other languages
English (en)
Inventor
Roman Dr Amrein
Ravi Dr Anand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HOFFMANN LA ROCHE
F Hoffmann La Roche AG
Original Assignee
HOFFMANN LA ROCHE
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HOFFMANN LA ROCHE, F Hoffmann La Roche AG filed Critical HOFFMANN LA ROCHE
Application granted granted Critical
Publication of ES2063060T3 publication Critical patent/ES2063060T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE PUEDE UTILIZAR P - CLORO - N (2 - MORFOIINOETIL) BENZAMIDA PARA ENFERMEDADES COGNITIVAS Y PUEDEN DESPUES POR TRATAMIENTO EN SU CASO PREVENIR ENFERMEDADES COGNITIVAS, PRINCIPALMENTE DE AQUELLAS, QUE SOBREVIENEN CON LA EDAD.
ES89100901T 1988-01-28 1989-01-19 Benzamida contra enfermedades cognoscitivas. Expired - Lifetime ES2063060T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH29888 1988-01-28

Publications (1)

Publication Number Publication Date
ES2063060T3 true ES2063060T3 (es) 1995-01-01

Family

ID=4183804

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89100901T Expired - Lifetime ES2063060T3 (es) 1988-01-28 1989-01-19 Benzamida contra enfermedades cognoscitivas.

Country Status (15)

Country Link
US (1) US4906626A (es)
EP (1) EP0326023B1 (es)
JP (1) JPH07116043B2 (es)
KR (1) KR960016203B1 (es)
AT (1) ATE113207T1 (es)
AU (1) AU620584B2 (es)
CA (1) CA1332151C (es)
DE (1) DE58908544D1 (es)
DK (1) DK171094B1 (es)
ES (1) ES2063060T3 (es)
HU (1) HU203042B (es)
IE (1) IE65409B1 (es)
IL (1) IL89031A (es)
PH (1) PH26030A (es)
ZA (1) ZA89523B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2074981T3 (es) * 1986-12-17 1995-10-01 Glaxo Group Ltd Uso de derivados heterociclicos en el tratamiento de trastornos cognoscitivos.
FR2645742A1 (fr) * 1989-04-12 1990-10-19 Delagrange Laboratoires Application de derives de 2-methoxy 4-(4,5-dihydro 2-imidazolyl (ou 2-oxazolyl) amino) 5-chloro benzamide dans le traitement des troubles de la fonction cognitive
JP3172202B2 (ja) * 1990-11-29 2001-06-04 エフ．ホフマン−ラ ロシュ アーゲー 不安の障害の処置剤
US6951884B2 (en) * 2002-06-12 2005-10-04 Hoffmann-La Roche Inc. Fluorobenzamides and uses thereof
RU2006117366A (ru) * 2003-10-23 2007-12-10 Ф.Хоффманн-Ля Рош Аг (Ch) Производные бензазепина в качестве ингибиторов мао-в
WO2005053703A1 (en) * 2003-12-02 2005-06-16 Leslie James Sheldon Combination therapy for dementia, depression and apathy
US8173642B2 (en) 2005-10-25 2012-05-08 Shionogi & Co., Ltd. Aminodihydrothiazine derivatives
ES2476605T3 (es) 2007-04-24 2014-07-15 Shionogi & Co., Ltd. Derivados de aminohidrotiazina sustituidos con grupos cíclicos
EP2151435A4 (en) 2007-04-24 2011-09-14 Shionogi & Co PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
WO2009151098A1 (ja) * 2008-06-13 2009-12-17 塩野義製薬株式会社 βセクレターゼ阻害作用を有する含硫黄複素環誘導体
EP2360155A4 (en) * 2008-10-22 2012-06-20 Shionogi & Co 2-AMINOPYRIDIN-4-ON AND 2-AMINOPYRIDINE DERIVATIVE WITH BACE1-HEMDERING EFFECT
PH12012501081A1 (en) 2009-12-11 2012-10-29 Shionogi & Co Oxazine derivatives
WO2012057248A1 (ja) 2010-10-29 2012-05-03 塩野義製薬株式会社 ナフチリジン誘導体
US9018219B2 (en) 2010-10-29 2015-04-28 Shionogi & Co., Ltd. Fused aminodihydropyrimidine derivative
JPWO2012147763A1 (ja) 2011-04-26 2014-07-28 塩野義製薬株式会社 オキサジン誘導体およびそれを含有するｂａｃｅ１阻害剤
US9540359B2 (en) 2012-10-24 2017-01-10 Shionogi & Co., Ltd. Dihydrooxazine or oxazepine derivatives having BACE1 inhibitory activity
US10599006B2 (en) 2016-04-12 2020-03-24 E-Vision Smart Optics, Inc. Electro-active lenses with raised resistive bridges
KR20240165473A (ko) 2016-04-12 2024-11-22 이-비전 스마트 옵틱스, 아이엔씨. 융기 저항 브릿지를 가지는 전기-활성 렌즈

Also Published As

Publication number Publication date
EP0326023B1 (de) 1994-10-26
IE65409B1 (en) 1995-10-18
EP0326023A2 (de) 1989-08-02
HUT50042A (en) 1989-12-28
JPH07116043B2 (ja) 1995-12-13
DE58908544D1 (de) 1994-12-01
IL89031A (en) 1995-07-31
AU620584B2 (en) 1992-02-20
EP0326023A3 (en) 1990-09-05
US4906626A (en) 1990-03-06
IE890273L (en) 1989-07-28
ZA89523B (en) 1989-09-27
CA1332151C (en) 1994-09-27
IL89031A0 (en) 1989-08-15
KR960016203B1 (ko) 1996-12-06
JPH01224318A (ja) 1989-09-07
AU2883689A (en) 1989-08-03
DK36889D0 (da) 1989-01-27
DK171094B1 (da) 1996-06-03
PH26030A (en) 1992-01-29
ATE113207T1 (de) 1994-11-15
HU203042B (en) 1991-05-28
DK36889A (da) 1989-07-29
KR890011589A (ko) 1989-08-21

Similar Documents

Publication Publication Date Title
ES2063060T3 (es) Benzamida contra enfermedades cognoscitivas.
DE3788984D1 (de) Verwendung von Prostaglandin-D2-aktiven-Substanzen zur Behandlung von Augen-Hypertension und von Glaukom.
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
MX9803753A (es) Acidos alfa-iminohidroxamicos y -carboxilicos n-sustituidos ciclicos y heterociclicos.
DE58902094D1 (de) Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
DE3587741D1 (de) Behandlung von Hautkrankheiten.
ATE79761T1 (de) Behandlung einer krankheit vom aids-typ.
NO950784D0 (no) Fettsyrederivater
ATE79536T1 (de) Tamoxifen zur topischen verwendung.
FI864570A0 (fi) Terapeutiskt anvaendbar foerening.
EP0305890A3 (en) Use of bezafibrate for the treatment of diabetes
DE3587978D1 (de) Mittel zur Behandlung von Erkrankungen der Venen und des Analbereichs.
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
DE3679781D1 (de) Verwendung von zusammensetzungen fuer die behandlung und die prophylaxe von epithelialer zerstoerung.
DE3576689D1 (de) Oxa- und thiadiazolylderivate und ihre verwendung.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
GB8327598D0 (en) Pharmacologically active diarylindane-13-diones
ATE143058T1 (de) Typisierung humaner rhinoviren
DE59504374D1 (de) Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen
ATE22010T1 (de) Antipsychotische trans-dihydrolisuride.
DE3684825D1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
ATE79759T1 (de) Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
ATE56681T1 (de) Behandlung geschmeidiger gewebe.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 326023

Country of ref document: ES